Halozyme Therapeutics
HALO
#2358
Rank
HK$64.28 B
Marketcap
HK$542.62
Share price
3.98%
Change (1 day)
22.06%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: HK$64.28 Billion

As of April 2026 Halozyme Therapeutics has a market cap of HK$64.28 Billion. This makes Halozyme Therapeutics the world's 2358th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$64.28 B2.02%
2025HK$63.01 B32.55%
2024HK$47.53 B24.67%
2023HK$38.13 B-36.57%
2022HK$60.11 B36.18%
2021HK$44.14 B-1.38%
2020HK$44.75 B137.1%
2019HK$18.87 B13.85%
2018HK$16.58 B-26.42%
2017HK$22.53 B127.13%
2016HK$9.92 B-42.37%
2015HK$17.21 B82.92%
2014HK$9.41 B-29.32%
2013HK$13.31 B127.11%
2012HK$5.86 B-23.46%
2011HK$7.65 B23.55%
2010HK$6.19 B48.56%
2009HK$4.17 B18.4%
2008HK$3.52 B-18.39%
2007HK$4.31 B0.35%
2006HK$4.30 B406.21%
2005HK$0.85 B1.06%
2004HK$0.84 B

End of Day market cap according to different sources

On Apr 18th, 2026 the market cap of Halozyme Therapeutics was reported to be:

HK$64.28 Billion
by Nasdaq info icon info icon
HK$64.28 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.419 T 6,774.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.227 T 1,809.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$6.497 T 10,007.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$901.70 B 1,302.65%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
HK$75.64 B 17.66%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
HK$6.86 B-89.32%๐Ÿ‡บ๐Ÿ‡ธ USA